PRICE T ROWE ASSOCIATES INC /MD/ - VOYAGER THERAPEUTICS INC ownership

VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 59 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,100
-35.4%
1,174,087
-4.5%
0.00%
-50.0%
Q2 2023$14,084
+102.6%
1,229,981
+36.4%
0.00%
+100.0%
Q1 2023$6,951
+42.9%
901,465
+13.1%
0.00%0.0%
Q4 2022$4,863
-99.9%
797,321
-5.5%
0.00%0.0%
Q3 2022$4,996,000
+2.1%
843,711
+1.9%
0.00%0.0%
Q2 2022$4,893,000
+1322.4%
827,950
+1735.8%
0.00%
Q1 2022$344,000
+39.8%
45,100
-50.4%
0.00%
Q4 2021$246,000
+4.7%
90,900
+1.7%
0.00%
Q3 2021$235,000
-10.3%
89,400
+40.8%
0.00%
Q2 2021$262,000
-14.9%
63,500
-2.9%
0.00%
Q1 2021$308,000
-75.0%
65,378
-50.2%
0.00%
Q4 2018$1,233,000
-73.1%
131,202
-45.9%
0.00%
-100.0%
Q3 2018$4,587,000
+614.5%
242,434
+637.9%
0.00%
Q2 2018$642,000
-52.3%
32,854
-78.2%
0.00%
Q2 2017$1,347,000
+71.6%
150,384
+153.6%
0.00%
Q1 2017$785,000
-40.2%
59,291
-42.5%
0.00%
Q4 2016$1,313,000103,0550.00%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TRV GP III, LLC 6,391,176$45,697,0003.92%
ARMISTICE CAPITAL, LLC 3,392,000$24,253,0000.82%
Bellevue Group AG 2,712,083$19,391,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 141,924$1,015,0000.17%
XTX MARKETS LLC 10,578$76,0000.16%
Aevitas Wealth Management, Inc. 22,150$158,0000.12%
Virtus ETF Advisers LLC 35,079$251,0000.10%
HITE Hedge Asset Management LLC 29,357$210,0000.05%
LINCOLN CAPITAL CORP 10,000$72,0000.05%
CIM INVESTMENT MANAGEMENT INC 18,745$134,0000.04%
View complete list of VOYAGER THERAPEUTICS INC shareholders